Annual sales rose 8%, breaking through the $100m milestone for the first
time, to reach $103.5m.
• Strong demand in Asia, combined with product and market diversity,
insulated Comvita earnings from the worst impact of Manuka honey
shortages and honey cost increases.
• Manuka honey supply returning to normal as a result of an above average
2012-2013 summer flowering season and additional volumes through the
acquisition of an additional high-quality Manuka apiary business.
• A clinical trial on Comvita Fresh Olive Leaf Extract showed significant
positive results for blood sugar control in at-risk adult males.
• Continued strong growth in the medical honey category with annual royalties
now in excess of $1.3m.